Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992;21(3):214-20.
doi: 10.1007/BF02591649.

Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases

N Semeraro  1 , M Colucci
Affiliations
Review

Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases

N Semeraro et al. Int J Clin Lab Res. 1992.

Abstract

Over the last few years, evidence has accumulated that the pathogenetic mechanism of disseminated intravascular coagulation encountered in patients with infectious diseases is extraordinarily complex and involves multiple interactions between the microorganism itself and/or a number of mediators, both microorganism derived and host manufactured, and multifunctional cellular systems, namely endothelial cells and mononuclear phagocytes. In particular, infectious agents and mediators shift the coagulation-fibrinolysis equilibrium of these cells towards fibrin formation and accumulation, via enhancement of procoagulant properties and reduction of both anticoagulant and fibrinolytic capacities. New insights into the pathogenetic mechanism may have important implications for the management of infected patients with disseminated intravascular coagulation.

PubMed Disclaimer

References

    1. Almdahl SM, Brox JH, Osterud B. Mononclear phagocyte thromboplastin and endotoxin in patients with secondary peritonities. Scand J Gastroenterol. 1987;22:914–914. doi: 10.3109/00365528708991935. - DOI - PubMed
    1. Astedt B, Lecander I, Ny T. The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis. 1987;1:203–203. doi: 10.1016/0268-9499(87)90037-3. - DOI
    1. Bachman F. Fibrinolysis. In: Verstraete M, Vermylen J, Lijnen HR, Arnout J, editors. Thrombosis and haemostasis. Leuven: Leuven University Press; 1987. pp. 227–265.
    1. Bauer KA, ten Cate H, Barzegar S, Springgs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism in humans. Blood. 1989;74:165–165. - PubMed
    1. Baumgartner JD. Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock. Eur J Clin Microbiol Infect Dis. 1990;9:711–711. doi: 10.1007/BF02184682. - DOI - PubMed

MeSH terms

LinkOut - more resources